BackLENZ Therapeutics Overview
LENZ Therapeutics Inc.

LENZ Therapeutics Discounted Cash Flow

DCF Analysis for LENZ.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$1.09

Current Fair Value

$1.09
83.9% Downside

Overvalued by 83.9% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading